PostDoc-H. Lee Moffitt Cancer Center & Research Institute and the University of South Florida, USA
Location: Tampa, FL, United States
H. Lee Moffitt Cancer Center & Research Institute is a nonprofit cancer treatment and research center located in Tampa, Florida. Established in 1981 by the Florida Legislature, the hospital opened in October 1986, on the University of South Florida campus. Moffitt is the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida.
Funding for construction of the initial $70 million facility came primarily from the state of Florida’s cigarette tax, while the momentum to create the center came from a cadre of legislators, physicians, educators and business leaders who envisioned a new dimension of cancer care and research in Florida.
In late 1978, H. Lee Moffitt, a Florida State Representative, recognized the need for a comprehensive cancer center within the state after several friends died from cancer. An excellent negotiator, Moffitt put his plan into motion by first proposing the idea to Dr. Hollis Boren, then dean of the University of South Florida College of Medicine. Over lunch at the Tampa Club, Moffitt proposed his idea. By dessert, Boren has signed on. “Out of that discussion came plans for a plug-shaped, multilevel cancer research teaching hospital to be built a short walk away from the USF clinics,” The Tampa Times reported on Feb. 5, 1979. Moffitt and Boren had gathered information about the need for a comprehensive cancer center, the article said, and the need was great. Moffitt sought community support and convinced the State Legislature to fund the facility. During the center’s planning phase, consultants associated with NCI-designated Cancer Centers were retained to ensure that the finished facility would be as technologically advanced and as efficiently designed as possible.
A postdoctoral position is available in the lab of Dr. Jiandong Chen at the H. Lee Moffitt Cancer Center in Tampa, Florida to study the structures, regulation, and therapeutic targeting of p53, MDM2 and MDMX proteins. Successful applicant will be a highly motivated recent graduate with a Ph.D. degree in biochemistry and molecular biology. Experience with signal transduction, drug discovery, structural biology will be desirable.
How to apply
Please send CV and contact information of 3 reference to firstname.lastname@example.org.
Link to publications from Dr. Chen¹s lab: